Spots Global Cancer Trial Database for effect of drug
Every month we try and update this database with for effect of drug cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care. | NCT05154201 | Effect of Drug | ORIN1001 | 18 Years - | Orinove, Inc. | |
Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy | NCT06114758 | Hemorrhage, Sur... Myoma;Uterus Effect of Drug Postoperative H... Postoperative C... | Cytotec 200Mcg ... Transamine | 18 Years - 45 Years | Ankara Etlik City Hospital | |
Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy | NCT06114758 | Hemorrhage, Sur... Myoma;Uterus Effect of Drug Postoperative H... Postoperative C... | Cytotec 200Mcg ... Transamine | 18 Years - 45 Years | Ankara Etlik City Hospital | |
Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma | NCT04824352 | Effect of Drug Toxicity, Drug | apatinib | 12 Years - 70 Years | Peking University People's Hospital | |
Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC) | NCT05543304 | Hepatocellular ... Effect of Drug | radiological ev... | 18 Years - 80 Years | First Affiliated Hospital of Wenzhou Medical University | |
Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors | NCT04960943 | Gastrointestina... Effect of Drug | Pyrotinib with ... | 18 Years - | Fudan University | |
Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC) | NCT05543304 | Hepatocellular ... Effect of Drug | radiological ev... | 18 Years - 80 Years | First Affiliated Hospital of Wenzhou Medical University | |
Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer | NCT05482451 | Effect of Drug | Nivolumab all trans retin... | 20 Years - 100 Years | China Medical University Hospital | |
Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors | NCT04960943 | Gastrointestina... Effect of Drug | Pyrotinib with ... | 18 Years - | Fudan University | |
Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE) | NCT05277480 | Effect of Drug Drug Toxicity | Apatinib+IE IE | 12 Years - 65 Years | Peking University People's Hospital | |
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma | NCT04690231 | Effect of Drug Toxicity, Drug Secondary Resis... | Apatinib Mesyla... ifosfamide and ... | 3 Years - | Peking University People's Hospital | |
Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care. | NCT05154201 | Effect of Drug | ORIN1001 | 18 Years - | Orinove, Inc. | |
Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma | NCT05252429 | Effect of Drug | Docetaxel Pembrolizumab | 20 Years - | Hokkaido University Hospital | |
Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC) | NCT05543304 | Hepatocellular ... Effect of Drug | radiological ev... | 18 Years - 80 Years | First Affiliated Hospital of Wenzhou Medical University | |
Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC) | NCT05543304 | Hepatocellular ... Effect of Drug | radiological ev... | 18 Years - 80 Years | First Affiliated Hospital of Wenzhou Medical University | |
Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma | NCT05252429 | Effect of Drug | Docetaxel Pembrolizumab | 20 Years - | Hokkaido University Hospital |